|
Feb 12
|
Dow Jones Futures: Market Risks Rising With 5 Stocks In Buy Zones
|
|
Feb 12
|
Intra-Cellular Therapies, Inc.'s (NASDAQ:ITCI) Path To Profitability
|
|
Jan 13
|
Intra-Cellular Therapies Inc EVP and General Counsel Michael Halstead Sells 50,000 Shares
|
|
Jan 12
|
16 Best Mid-Cap Growth Stocks To Buy Now
|
|
Jan 5
|
Intra-Cellular Therapies Inc EVP Suresh Durgam Sells 62,282 Shares
|
|
Jan 1
|
Intra-Cellular Therapies (ITCI) Now Trades Above Golden Cross: Time to Buy?
|
|
Dec 20
|
11 Most Promising Psychedelic Stocks According to Hedge Funds
|
|
Dec 19
|
Intra-Cellular Therapies (ITCI) is a Great Momentum Stock: Should You Buy?
|
|
Dec 18
|
3 Biotech Stocks Most Wall Street Analysts Are Bullish About
|
|
Dec 13
|
IBD 50 Stocks To Watch: Biotech Leader Intra-Cellular Therapies Is Breaking Out Past A New Buy Point
|
|
Dec 8
|
Why Is Biogen Inc. (BIIB) Up 6.4% Since Last Earnings Report?
|
|
Dec 5
|
Intra-Cellular Therapies Highlights Data Presentations at the American College of Neuropsychopharmacology Annual Meeting
|
|
Nov 7
|
Wall Street Analysts Believe Intra-Cellular (ITCI) Could Rally 41.19%: Here's is How to Trade
|
|
Nov 6
|
We Think Intra-Cellular Therapies (NASDAQ:ITCI) Can Easily Afford To Drive Business Growth
|
|
Nov 3
|
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q3 2023 Earnings Call Transcript
|
|
Nov 2
|
Intra-Cellular Therapies Inc (ITCI) Reports Q3 2023 Earnings, Raises Sales Guidance
|
|
Nov 2
|
Intra-Cellular Therapies Reports Third Quarter 2023 Financial Results and Raises 2023 CAPLYTA Sales Guidance
|
|
Aug 4
|
Intra-Cellular (ITCI) Q2 Earnings & Sales Top, '23 View Raised
|
|
Aug 4
|
Intra-Cellular Therapies to Present at the Canaccord Genuity 43rd Annual Growth Conference
|
|
Apr 27
|
Intra-Cellular Therapies (ITCI) Expected to Beat Earnings Estimates: Should You Buy?
|